» Articles » PMID: 26520409

Recent Advances in Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for in Vitro and in Vivo Cancer Nanotheranostics

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2015 Nov 2
PMID 26520409
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Recently superparamagnetic iron oxide nanoparticles (SPIONs) have been extensively used in cancer therapy and diagnosis (theranostics) via magnetic targeting, magnetic resonance imaging, etc. due to their remarkable magnetic properties, chemical stability, and biocompatibility. However, the magnetic properties of SPIONs are influenced by various physicochemical and synthesis parameters. So, this review mainly focuses on the influence of spin canting effects, introduced by the variations in size, shape, and organic/inorganic surface coatings, on the magnetic properties of SPIONs. This review also describes the several predominant chemical synthesis procedures and role of the synthesis parameters for monitoring the size, shape, crystallinity and composition of the SPIONs. Moreover, this review discusses about the latest developments of the inorganic materials and organic polymers for encapsulation of the SPIONs. Finally, the most recent advancements of the SPIONs and their nanopackages in combination with other imaging/therapeutic agents have been comprehensively discussed for their effective usage as in vitro and in vivo theranostic agents in cancer treatments.

Citing Articles

Nanomedicine Innovations for Lung Cancer Diagnosis and Therapy.

Cardoso V, Bistaffa M, Sterman R, Lima L, Toldo G, Cancino-Bernardi J ACS Appl Mater Interfaces. 2025; 17(9):13197-13220.

PMID: 40045524 PMC: 11891907. DOI: 10.1021/acsami.4c16840.


Utilization of nanomaterials in MRI contrast agents and their role in therapy guided by imaging.

Wang W, Shang S, Wang Y, Xu B Front Bioeng Biotechnol. 2024; 12:1484577.

PMID: 39628648 PMC: 11611570. DOI: 10.3389/fbioe.2024.1484577.


Aminoacid functionalised magnetite nanoparticles FeO@AA (AA = Ser, Cys, Pro, Trp) as biocompatible magnetite nanoparticles with potential therapeutic applications.

Angela S, Ludmila M, Cornelia-Ioana I, Denisa F, Cristina C, Natalia P Sci Rep. 2024; 14(1):26228.

PMID: 39482399 PMC: 11528115. DOI: 10.1038/s41598-024-76552-1.


What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible....

Szupryczynski K, Czelen P, Jelinski T, Szefler B Int J Nanomedicine. 2024; 19:9503-9547.

PMID: 39296940 PMC: 11410046. DOI: 10.2147/IJN.S469217.


Optimization of micelle-encapsulated extremely small sized iron oxide nanoparticles as a T1 contrast imaging agent: biodistribution and safety profile.

Suh M, Park J, Ko G, Kim J, Hwang D, Rees L J Nanobiotechnology. 2024; 22(1):419.

PMID: 39014410 PMC: 11253436. DOI: 10.1186/s12951-024-02699-8.